Avadel Pharmaceuticals Announces Publication of Real-World Data Highlighting the Risk of Accidental Dosing Errors with Immediate-Release Twice-Nightly Oxybates

Stock Information for Avadel Pharmaceuticals plc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 9
Avadel Presents New Real-World Data Describing Demographic Characteristics and Comorbidities of Patients with Narcolepsy at ANA 2022

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.